TY  - JOUR
PY  - 2024//
TI  - Suicide attempt in a dopamine agonist withdrawal syndrome in Parkinson's disease
JO  - Parkinsonism and related disorders
A1  - Espindola, Melisa
A1  - Rojas, Natalia González
A1  - Vaisentein, Giselle
A1  - Da Prat, Gustavo
A1  - Cesarini, Martin
A1  - Etcheverry, Jose Luis
A1  - Gatto, Emilia M.
SP  - e106017
EP  - e106017
VL  - 121
IS  - 
N2  - Dopamine agonist withdrawal syndrome (DAWS) results from the reduction or suspension of dopamine agonist medications; it encompasses mainly psychiatric symptoms, including suicidal behaviors. In patients with Parkinson's disease (PD), the impact of DAWS can be significant in terms of distress and disability; however, we must take this syndrome into account as a threatening condition because suicidal behaviors could be developing in the context of DAWS. Here we present a brief case of DAWS affecting a young man with PD, whom abruptly discontinued DA treatment and developed psychiatric symptoms within two weeks which led to a suicidal attempt.<p />  <p>Language: en</p>
LA  - en
SN  - 1353-8020
UR  - http://dx.doi.org/10.1016/j.parkreldis.2024.106017
ID  - ref1
ER  -